Home
Companies
Mammoth Biosciences

Mammoth Biosciences Stock

Company Profile:

Mammoth Biosciences is a biotechnology company based in Brisbane, California, that focuses on developing diagnostic tests and therapies using advanced CRISPR technology. Founded in 2017 by notable figures including Nobel laureate Jennifer Doudna, the company aims to leverage its proprietary ultracompact CRISPR systems for various applications, including gene editing and decentralized precision diagnostics.

Sign up for SecondMarket™ to view the market and buy or sell Mammoth Biosciences Stock

Buy + Sell

Mammoth Biosciences Funding

Sign up to gain insights into Mammoth Biosciences funding history, including the funding round, time period, and amount raised.

Date	Financing Round	Amount	Price per share*	Valuation*
Apr 22, 2024	Series D	106.69M	Price	Valuation
Aug 05, 2021	Series D	150.00M	Price	Valuation
May 19, 2020	Series C	49.25M	Price	Valuation
May 19, 2020	Series C	747.77K	Price	Valuation
Feb 24, 2020	Series B	36.77M	Price	Valuation
Feb 24, 2020	Series B	7.41M	Price	Valuation
Feb 25, 2019	Series A	4.94M	Price	Valuation
May 15, 2018	Series A	13.16M	Price	Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

See Mammoth Biosciences Valuations + Financials

*Sample data + company shown for illustrative purposes only

Gain insights Into Mammoth Biosciences Stock Valuation + Share Prices

View real-time Tape D™ data on Mammoth Biosciences stock including most recent valuation and historical share price information.

Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.

Get Started

Leverage Your Equity to Help Achieve More.

Mammoth Biosciences Management Team

Co-Founder, CEO, Director
Trevor Martin
Director
Maneesh Jain
Co-founder, Chief Science Officer
Lucas Harrington
Co-founder, Chair of Scientific Advisory Board
Jennifer A. Doudna
Co-Founder, Chief Technology Officer, Director
Janice Chen
Director
Min Cui
Director
Jeff Huber
Director
Jeremy Green

Mammoth Biosciences Major Investors

Verily Life Sciences LLC
Redmile Group
Decheng Capital LLC
Greenspring Associates, Inc
Greenspring Associates, Inc
Foresite Capital
Senator Investment Group
8VC
Plum Alley Co.
Sixth Street Partners
Mayfield Fund
Pacific 8 Ventures
aMoon Fund
NFX

Learn More About Mammoth Biosciences Stock

Buy Mammoth Biosciences Stock

Mammoth Biosciences stock does not trade on public stock exchanges. Mammoth Biosciences stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Mammoth Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.

Sell Mammoth Biosciences Stock

Mammoth Biosciences Stock does not trade on public stock exchanges. In order to sell Mammoth Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.

Mammoth Biosciences Stock Price

Mammoth Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Mammoth Biosciences share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.

Mammoth Biosciences Stock Ticker Symbol

There is no ticker symbol for Mammoth Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.

Criteria to Sell Mammoth Biosciences Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mammoth Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Criteria to Buy or Invest in Mammoth Biosciences Stock

Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Mammoth Biosciences stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.

Mammoth Biosciences Stock Settlement

Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

Mammoth Biosciences IPO

Mammoth Biosciences is a private company and has not had an IPO. There is currently no Mammoth Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Mammoth Biosciences IPO.